Edwards Lifesciences (EW) Holder United Capital Financial Advisers Has Cut Holding; As Apple (AAPL) Stock Declined, Holder Penn Davis Mcfarland Lowered Its Stake

May 21, 2018 - By Linda Rogers

Edwards Lifesciences Corporation (NYSE:EW) Logo

United Capital Financial Advisers Llc decreased its stake in Edwards Lifesciences Corp (EW) by 39.08% based on its latest 2017Q4 regulatory filing with the SEC. United Capital Financial Advisers Llc sold 5,384 shares as the company’s stock rose 22.78% while stock markets declined. The institutional investor held 8,394 shares of the industrial specialties company at the end of 2017Q4, valued at $946,000, down from 13,778 at the end of the previous reported quarter. United Capital Financial Advisers Llc who had been investing in Edwards Lifesciences Corp for a number of months, seems to be less bullish one the $28.92 billion market cap company. The stock increased 0.93% or $1.26 during the last trading session, reaching $137.21. About 548,567 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 44.06% since May 21, 2017 and is uptrending. It has outperformed by 32.51% the S&P500.

Penn Davis Mcfarland Inc decreased its stake in Apple Inc. (AAPL) by 1.16% based on its latest 2017Q4 regulatory filing with the SEC. Penn Davis Mcfarland Inc sold 1,780 shares as the company’s stock declined 3.81% with the market. The institutional investor held 152,324 shares of the computer manufacturing company at the end of 2017Q4, valued at $25.78 million, down from 154,104 at the end of the previous reported quarter. Penn Davis Mcfarland Inc who had been investing in Apple Inc. for a number of months, seems to be less bullish one the $921.84 billion market cap company. The stock increased 0.67% or $1.24 during the last trading session, reaching $187.55. About 16.53M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since May 21, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on August, 7. They expect $2.19 EPS, up 31.14% or $0.52 from last year’s $1.67 per share. AAPL’s profit will be $10.76B for 21.41 P/E if the $2.19 EPS becomes a reality. After $2.73 actual EPS reported by Apple Inc. for the previous quarter, Wall Street now forecasts -19.78% negative EPS growth.

Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 37 have Buy rating, 1 Sell and 18 Hold. Therefore 66% are positive. Apple Inc. had 414 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by UBS given on Monday, November 27. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Thursday, February 1 by RBC Capital Markets. Oppenheimer maintained Apple Inc. (NASDAQ:AAPL) rating on Tuesday, August 11. Oppenheimer has “Outperform” rating and $155 target. The rating was maintained by Loop Capital Markets on Thursday, September 14 with “Buy”. The stock of Apple Inc. (NASDAQ:AAPL) earned “Buy” rating by Mizuho on Wednesday, October 12. BTIG Research maintained the shares of AAPL in report on Thursday, April 7 with “Buy” rating. The rating was maintained by PiperJaffray on Wednesday, October 26 with “Overweight”. The rating was maintained by Pacific Crest with “Overweight” on Friday, January 8. The rating was downgraded by BMO Capital Markets to “Market Perform” on Wednesday, January 31. The rating was maintained by Needham on Thursday, July 27 with “Buy”.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Livetradingnews.com which released: “Apple Inc. (NASDAQ:AAPL) Upward Trend” on May 17, 2018, also Investorplace.com with their article: “4 Huge Risks for Apple Inc. Stock: The In-Depth Bear Case” published on May 18, 2018, Seekingalpha.com published: “Don’t Sell Micron Technology Because Of Trade War” on May 21, 2018. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Seekingalpha.com and their article: “Apple’s Dividend: An Opportunity Wasted” published on May 15, 2018 as well as Seekingalpha.com‘s news article titled: “Tim Cook comments on Trump meeting” with publication date: May 15, 2018.

Since December 7, 2017, it had 0 insider purchases, and 8 selling transactions for $42.88 million activity. 15,653 shares valued at $2.90M were sold by WILLIAMS JEFFREY E on Tuesday, May 8. On Wednesday, May 9 the insider LEVINSON ARTHUR D sold $6.51M. Another trade for 39,122 shares valued at $6.83 million was sold by Maestri Luca. AHRENDTS ANGELA J sold $6.75M worth of stock or 38,228 shares. On Tuesday, April 3 the insider SCHILLER PHILIP W sold $11.56 million.

Penn Davis Mcfarland Inc, which manages about $575.68 million and $341.35 million US Long portfolio, upped its stake in Celgene Corporation (NASDAQ:CELG) by 101,686 shares to 169,526 shares, valued at $17.69M in 2017Q4, according to the filing.

Investors sentiment increased to 0.73 in 2017 Q4. Its up 0.03, from 0.7 in 2017Q3. It is positive, as 50 investors sold AAPL shares while 1023 reduced holdings. 151 funds opened positions while 637 raised stakes. 2.98 billion shares or 0.18% more from 2.97 billion shares in 2017Q3 were reported. Sather Finance Gru owns 3,686 shares for 0.16% of their portfolio. Live Your Vision Lc, Pennsylvania-based fund reported 5,874 shares. Birmingham Management Co Al holds 0.43% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 6,564 shares. Hightower Limited owns 1.86M shares or 2.58% of their US portfolio. Moreover, Penobscot Inv Mngmt Communications Inc has 2.09% invested in Apple Inc. (NASDAQ:AAPL). Asset Mngmt invested 2.69% in Apple Inc. (NASDAQ:AAPL). Caxton Assoc Lp reported 0.35% stake. Institute For Wealth Management Ltd Liability accumulated 63,263 shares or 2.48% of the stock. Moreover, Tiemann Advsr Ltd Co has 4.1% invested in Apple Inc. (NASDAQ:AAPL) for 30,408 shares. Moreover, American Century has 2.36% invested in Apple Inc. (NASDAQ:AAPL). Hollow Brook Wealth Mgmt Limited owns 47,260 shares. Glenmede Tru Na owns 2.38 million shares. Sequoia Financial Ltd Liability Corporation reported 3.66% of its portfolio in Apple Inc. (NASDAQ:AAPL). Gratry Communications Limited Liability Com owns 1,899 shares for 0.39% of their portfolio. Alexandria Cap Ltd Liability holds 2.3% in Apple Inc. (NASDAQ:AAPL) or 93,100 shares.

More notable recent Edwards Lifesciences Corporation (NYSE:EW) news were published by: Investorplace.com which released: “3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)” on April 25, 2018, also Profitconfidential.com with their article: “Despite the Sell-Off, Edwards Life Sciences Stock Still Remains Bullish” published on April 30, 2018, Seekingalpha.com published: “Edwards Lifesciences: Treating The #1 Killer In America” on May 12, 2018. More interesting news about Edwards Lifesciences Corporation (NYSE:EW) were released by: Globenewswire.com and their article: “Market Trends Toward New Normal in Anadarko Petroleum, Edwards Lifesciences, American Eagle Outfitters, Express …” published on May 07, 2018 as well as Seekingalpha.com‘s news article titled: “Edwards Lifesciences’ (EW) CEO Michael Mussallem on Q1 2018 Results – Earnings Call Transcript” with publication date: April 25, 2018.

Among 28 analysts covering Edwards Lifesciences Corp (NYSE:EW), 21 have Buy rating, 1 Sell and 6 Hold. Therefore 75% are positive. Edwards Lifesciences Corp had 112 analyst reports since July 30, 2015 according to SRatingsIntel. Barclays Capital maintained the stock with “Equalweight” rating in Wednesday, July 27 report. Northland Capital maintained it with “Buy” rating and $11000 target in Thursday, July 27 report. The firm earned “Buy” rating on Sunday, October 8 by Canaccord Genuity. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, April 26. Cowen & Co initiated it with “Outperform” rating and $185 target in Friday, October 9 report. Guggenheim initiated the shares of EW in report on Thursday, June 9 with “Neutral” rating. The stock has “Buy” rating by SunTrust on Tuesday, April 10. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Neutral” rating given on Tuesday, January 2 by JP Morgan. BMO Capital Markets maintained Edwards Lifesciences Corporation (NYSE:EW) rating on Thursday, August 31. BMO Capital Markets has “Buy” rating and $132.0 target.

Apple Inc. (NASDAQ:AAPL) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>